Our CJC-1295 (No DAC) / Ipamorelin Blend combines a growth hormone-releasing hormone (GHRH) analogue with a selective ghrelin receptor agonist, providing researchers with a practical tool for investigating multiple pathways involved in growth hormone axis regulation.

This research peptide blend is frequently utilised in laboratory studies examining receptor signalling, endocrine pathway interactions, and the coordinated effects of GHRH and ghrelin receptor activation. By combining CJC-1295 (No DAC) and Ipamorelin in a defined ratio, researchers can evaluate comparative and complementary signalling behaviours within controlled experimental environments.

The blend format simplifies experimental design where consistent proportions between compounds are required across repeated assays, receptor-binding studies, and cell-signalling investigations. Manufactured to research-grade standards, each batch is supported by analytical documentation and quality control processes suitable for serious laboratory research.

Disclaimer: For scientific research use only. Not for human or animal use or consumption.